Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/06/2010US20100111929 Method of treating peripheral nerve disorders
05/06/2010US20100111928 Methods and kits for diagnosis tumorgenicity
05/06/2010US20100111924 Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site
05/06/2010US20100111922 Animal model and use of 17beta-hydroxysteroid dehydrogenase type 7 in the diagnosis of anencephaly
05/06/2010US20100111921 Use of IL-1 Antagonists to Treat Gout
05/06/2010US20100111920 Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases
05/06/2010US20100111919 Delayed gelation compositions and methods of use
05/06/2010US20100111917 Cell-adhesive polyelectrolyte material for use as membrane and coating
05/06/2010US20100111907 Methods and compositions for gene inactivation
05/06/2010US20100111901 Triazole inhibitors of aromatase
05/06/2010US20100111900 Heterocyclic antiviral compounds
05/06/2010US20100111898 Conjoint therapy for treating fibrotic diseases
05/06/2010US20100111894 Metap-2 inhibitor polymersomes for therapeutic administration
05/06/2010US20100111893 Silicone Elastomer Exfoliating Compositions
05/06/2010US20100111892 Crosslinked polyfluoroacrylic acid and processes for the preparation thereof
05/06/2010US20100111891 Linear polyol stabilized polyfluoroacrylate compositions
05/06/2010US20100111888 Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions
05/06/2010US20100111883 Cyclodextrin formulations
05/06/2010US20100111874 Method of cancer detection and treatment
05/06/2010US20100111873 Treating cancer with viral nucleic acid
05/06/2010US20100111867 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging
05/06/2010US20100111866 Receptor and Antigen Targeted Prodrug
05/06/2010US20100111858 Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands
05/06/2010US20100111855 Frozen compositions and methods for piercing a substrate
05/06/2010US20100111845 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010US20100111844 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010US20100111843 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010US20100111842 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010US20100111839 Selective inhibitors of translesion dna replication
05/06/2010US20100108059 Directional use
05/06/2010DE202009010918U1 Fester Grundstoff für Pharmazeutika und Kosmetika mit Aminosalzen von natürlichen Fettsäuren Fixed a raw material for pharmaceuticals and cosmetics with amino salts of natural fatty acids
05/06/2010DE102008054300A1 Use and composition of pharmaceutical formulations for metabolic activation of analgesic effects in chronic pain, where polyphenolic flavonoids are used in the formulations and influence membrane potential of afferent neurons
05/06/2010DE102008054205A1 Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie Use of helium-oxygen gas mixtures for the treatment of pulmonary arterial hypertension
05/06/2010DE102004059674B4 Transdermales System zur Abgabe von Scopolamin The transdermal delivery system of scopolamine
05/06/2010CA2779261A1 Filamin a binding anti-inflammatory and analgesic
05/06/2010CA2779252A1 Filamin a-binding anti-inflammatory analgesic
05/06/2010CA2779178A1 Analgesic that binds filamin a
05/06/2010CA2742650A1 Nanoparticles of beta-lactam derivatives
05/06/2010CA2742364A1 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same
05/06/2010CA2742322A1 Azepino[4,5-b]indoles and methods of use
05/06/2010CA2742320A1 Pyrido[4,3-b]indoles containing rigid moieties
05/06/2010CA2742306A1 Compounds for the treatment of osteoporosis and cancers
05/06/2010CA2742227A1 Fatty acids for use as a medicament
05/06/2010CA2742213A1 Fruit extracts
05/06/2010CA2742181A1 Statin nanoparticles
05/06/2010CA2742007A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/06/2010CA2741988A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
05/06/2010CA2741954A1 Composition and method for treating fibrosis
05/06/2010CA2741941A1 Choline and tromethamine salt of licofelone
05/06/2010CA2741934A1 Thienotriazolodiazepine derivatives active on apo a
05/06/2010CA2741862A1 Compositions containing delta-9-thc-amino acid esters and process of preparation
05/06/2010CA2741846A1 Pharmaceutical compositions containing diacerein
05/06/2010CA2741838A1 S1p lyase inhibitors for the treatment of cerebral malaria
05/06/2010CA2741793A1 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/06/2010CA2741709A1 Substituted spiroamines
05/06/2010CA2741672A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
05/06/2010CA2741668A1 Novel substituted azabenzoxazoles
05/06/2010CA2741666A1 P2x3, receptor antagonists for treatment of pain
05/06/2010CA2741664A1 Method for selective control of helper t cell function
05/06/2010CA2741661A1 Novel amide derivative and use thereof as medicine
05/06/2010CA2741658A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010CA2741649A1 Pyridazine carboxamide orexin receptor antagonists
05/06/2010CA2741648A1 2,5-disubstituted phenyl carboxamide orexin receptor antagonists
05/06/2010CA2741646A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for disease accompanied by central nervous system disorders
05/06/2010CA2741629A1 Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
05/06/2010CA2741606A1 Novel salts of sunitinib
05/06/2010CA2741546A1 S1p receptor agonists for the treatement of cerebral malaria
05/06/2010CA2741517A1 Thyroid receptor ligands
05/06/2010CA2741352A1 Nutrition composition containing omega-3 fatty acids and mcts
05/06/2010CA2741325A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010CA2741259A1 Triazole beta carboline derivatives as antidiabetic compounds
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010CA2740792A1 Pyrazolopyrimidine jak inhibitor compounds and methods
05/06/2010CA2740558A1 Poly-heteroaryl derivatives for the treatment of cancer
05/06/2010CA2740058A1 An antidiabetic agent
05/06/2010CA2739883A1 Cyclohexane derivative and pharmaceutical use thereof
05/06/2010CA2738970A1 Topical composition comprising a combination of at least two penetration enhancing agents
05/06/2010CA2738909A1 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors
05/06/2010CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010CA2736953A1 Cepharosporins having a catechol group
05/06/2010CA2736361A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
05/05/2010EP2182067A2 Hybrid polyketide synthases
05/05/2010EP2182063A2 Modulation of EIF4E expression
05/05/2010EP2182004A1 Combination therapy of isotopically labelled chlorotoxin with temozolomide
05/05/2010EP2181998A1 New benzothiazinone derivative and its use as antibacterial agent
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010EP2181995A2 Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
05/05/2010EP2181994A1 Antimicrobial compounds
05/05/2010EP2181993A1 Antimicrobial oxazolidinone derivatives
05/05/2010EP2181992A1 Polycyclic compound
05/05/2010EP2181991A1 Novel salts of sunitinib
05/05/2010EP2181990A1 Piperidine derivative
05/05/2010EP2181988A1 Pharmaceutical Compositions based on Crystalline Form I of 5-Azacytidine
05/05/2010EP2181987A1 Heterocyclic compound and use thereof
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181984A1 AN OPTICALLY ACTIVE N- (alpha-MERCAPTOPROPIONY) GLYCINE
05/05/2010EP2181711A1 Cancer therapy using whole glucan particles and antibodies
05/05/2010EP2181710A1 Ligands for modulation of orphan receptor-gamma (NR1F3) activity
05/05/2010EP2181709A1 Synergic combination of analgesic compounds
1 ... 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 2302 ... 7860